This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Probe-based Confocal Laser Endomicroscopy (pCLE) is a novel imaging technology that enables real-time in-vivo microscopic visualization of tissue microarchitecture during endoscopy. It is being used to diagnose and treat diseases in the gastrointestinal (GI) tract. This imaging modality is based on laser scanning confocal microscopy, which has been used in research for decades. In pCLE, a thin fiberoptic probe is placed in contact with the tissue to obtain microscopic images. The probe is connected to a light source and a scanning device, allowing the probe to move back and forth, scanning the tissue and generating a microscopic image. The advantages of pCLE over traditional endoscopy are that it can provide real-time images of the microarchitecture of the GI tract, allowing for a more detailed diagnosis and treatment. In addition, the images can be used to detect changes in tissue structure and function, providing further diagnostic information. pCLE can be used for a variety of applications, including the detection of cancer and dysplasia in the GI tract, monitoring of inflammatory bowel disease, and assessment of mucosal integrity. In addition, pCLE can be used to identify and characterize microorganisms, such as Helicobacter pylori, which is associated with gastritis and ulcers. As the technology continues to evolve, pCLE has the potential to revolutionize the diagnosis and treatment of diseases in the GI tract. With its ability to provide real-time microscopic images of the GI tract, pCLE has the potential to transform diagnosis and treatment of GI diseases.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States